RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma

Details for Australian Patent Application No. 2006223131 (hide)

Owner Alcon, Inc.

Inventors Clark, Abbot F.; Chatterton, Jon E.; Mcnatt, Loretta Graves; Wang, WanHeng

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006223131

PCT Pub. Number WO2006/099353

Priority 60/660,556 11.03.05 US; 60/688,633 08.06.05 US

Filing date 10 March 2006

Wipo publication date 21 September 2006

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61P 27/06 (2006.01) Drugs for disorders of the senses

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/099353 Priority application(s): WO2006/099353

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006223136-Antimicrobial compositions comprising esters of hydroxycarboxylic acids

2006223129-Hydrocodone polymorphs